RTRX earnings call for the period ending March 31, 2019.
News & Analysis: Retrophin
These two growth stocks are poised for enormous gains.
RTRX earnings call for the period ending December 31, 2018.
The biopharma's stock skyrocketed in response to strong phase 2 clinical trial results.
Shares pop on rumors of a potential buyout.
News of an incoming competitor pushed shares lower in early trading.
Biotech CEO Martin Shkreli was arrested today on charges of securities fraud.
Tips to avoid falling victim to financial fraud.
Federal investigators have arrested the former hedge fund manager for securities fraud.
Retrophin finds itself under scrutiny by the Senate over its decision to increase the price of a drug it acquired in 2014.